Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2019-07-12
4:34 pm
Sale
13DArbutus Biopharma Corporation
ABUS
SVF Investments (UK) Ltd0
0%
-16,013,540decrease
(Position Closed)
View
2019-07-12
4:32 pm
Sale
13DUrovant Sciences Ltd.
UROV
SVF Investments (UK) Ltd0
0%
-22,703,669decrease
(Position Closed)
View
2019-07-12
4:31 pm
Sale
13DMyovant Sciences Ltd.
MYOV
SVF Investments (UK) Ltd0
0%
-40,765,599decrease
(Position Closed)
View
2019-07-12
4:29 pm
Sale
13DSio Gene Therapies Inc.
SIOX
SVF Investments (UK) Ltd0
0%
-105,952,381decrease
(Position Closed)
View
2019-06-05
4:22 pm
Purchase
13DMyovant Sciences Ltd.
MYOV
SVF Investments (UK) Ltd40,765,599
45.56%
2,424,242increase
(+6.32%)
View
2019-03-19
4:58 pm
Purchase
13DSio Gene Therapies Inc.
SIOX
SVF Investments (UK) Ltd105,952,381
58.15%
6,666,667increase
(+6.71%)
View
2018-12-20
07:00 am
Purchase
13DSio Gene Therapies Inc.
SIOX
SVF Investments (UK) Ltd99,285,714
65.2%
10,000,000increase
(+11.20%)
View
2018-10-10
5:09 pm
Purchase
13DUrovant Sciences Ltd.
UROV
SVF Investments (UK) Ltd22,703,669
75.6%
22,703,669increase
(New Position)
View
2018-06-07
08:31 am
Purchase
13DSio Gene Therapies Inc.
SIOX
SVF Investments (UK) Ltd89,285,714
73.1%
14,285,714increase
(+19.05%)
View
2018-04-04
4:51 pm
Purchase
13DMyovant Sciences Ltd.
MYOV
SVF Investments (UK) Ltd38,341,357
62.87%
1,110,015increase
(+2.98%)
View